NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Wednesday that its first quarter revenues increased 54 percent year over year as its instrument sales doubled.

The Seattle-based molecular diagnostics firm brought in total revenues of $8.8 million for the three months ended March 31, up from $5.7 million in the first quarter of 2013. It beat the average Wall Street estimate of $8.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.